Pediatric neurologic emergency may 2002.ppt

AbdulrahmanHamdy6 33 views 51 slides Sep 19, 2024
Slide 1
Slide 1 of 51
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49
Slide 50
50
Slide 51
51

About This Presentation

Pediatric neurologic emergency may 2002.ppt


Slide Content

pediatric neurologic pediatric neurologic
emergenciesemergencies
may 2002 core rounds

contentscontents
seizures
–approaches to
febrile seizure
new onset non-febrile seizure
established seizure disorder with recurrence
neonatal seizures
status epilepticus
–investigation, treatment, disposition
headache
–discussion (as little evidence to support)
migraine treatment
imaging indications

case 1case 1
2 year old
parents “shaking episode” lasting “10 mins”
EMS called - child no longer shaking
V/S - BP 105/60 HR 100 RR 18 Sat N T39

approach?
–well looking child

first event

multiple events
–sick looking child

case 2case 2
8 year old
parents describe good history for tonic-clonic activity
lasting 2 mins
1st event
post event confusion - improving
in ED - V/S N, N sensorium, N neuro exam
otherwise healthy, no meds, no allergies
approach?

case 3case 3
16 year old
known seizure disorder, on phenytoin
typical seizure presenting complaint
V/S N, neuro N, otherwise looks well
approach?

case 4case 4
2 week old
parents - “doesn’t look right”, “mouth opening and
closing”
one episode lasting 1 minute
child not interested in feeding, sleepy
V/S - BP 90/50 HR 130 RR 38 sat N T 37.8
otherwise normal exam
approach?

definitionsdefinitions
febrile seizure – NIH defn - event of
infancy/childhood, typically between age
3mo and 5yrs, with no evidence intracranial
infection or defined cause
epilepsy - two or more seizures not
provoked by a specific event such as fever,
trauma, infection, or chemical change

definitionsdefinitions
neonatal seizure – in first 28 days of life
(typically first few days)
status epilepticus
–seizure lasting >30 mins

NB rosen 5-10 mins
–sequential seizures without regain LOC >30min

classificationclassification
generalized
–LOC
–tonic, clonic, tonic-clonic, myoclonic, atonic, absence
partial – focal onset
–simple partial – no LOC
–complex partial – LOC
–partial secondarily generalized
unclassified

etiologyetiology
infectious
metabolic
traumatic
toxic
neoplastic
epileptic
other

differential diagnosisdifferential diagnosis
syncope
breath holding
sleep disorders (eg. narcolepsy)
paroxysmal movement disorder
–tics,tremors
migraines
psychogenic seizures

approach to febrile seizuresapproach to febrile seizures
the numbersthe numbers
epidemiology
–age 3mo – 5yrs
–peak age 9-20 mo
–2-5% children will have before age 5
–25-40% will have family history
–80 – 97% simple
–3 - 20% complex

simple febrile seizuresimple febrile seizure
< 15 mins
no focal features
no greater than 1 episode in 24h
neurologically and developmentally normal

complex febrile seizurecomplex febrile seizure
>15 min
–febrile epilepticus >30min or recurrent without
regaining consciousness > 30min
focal
recurrence within 24h

what do parents want to what do parents want to
know?know?
recurrence
–risk recurrence 25-50%
–risk recurrence after 2
nd
– 50%
–most recurrences within 6-12 mo
(20% within same febrile illness)
risk of epilepsy
–2-3% (baseline 1%)
–increased in
family history of epilepsy
abnormal developmental status
complex febrile seizure

neonatal seizureneonatal seizure
brief and subtle
–eye blinking
–mouth/tongue movements
–“bicycling” motion to limbs
typically sz’s can’t be provoked/consoled
autonomic changes
EEG less predictable

neonatal seizureneonatal seizure
etiology
–hypoxic-ischemic encephalopathy
Presents within first day
–congenital CNS anomalies
–intracranial hemorrhage
–electrolyte abnormalities – hypoglycemia and
hypocalcemia
–infections
–drug withdrawal
–pyrodoxine deficiency

status epilepticusstatus epilepticus
definition
–deizure lasting >30 mins

NB Rosen 5-10 mins
–sequential seizures without regain LOC >30min
mortality in pediatric status epilepticus 4%
morbidity may be as high as 30%

SE treatment considerationsSE treatment considerations
ABC’s
brief directed Hx and Px
glucose
antibiotics/antivirals
–if meningitis/encephalitis considered

SE treatmentSE treatment
1
st
line anticonvulsants
–IV

lorazepam 0.1mg/kg

diazepam 0.2 mg/kg

midazolam 0.2 mg/kg
–rectal diazepam

2-5 yrs – 0.5 mg/kg

6-11 yrs – 0.3 mg/kg

>12 yrs – 0.2 mg/kg
–IM, intranasal, buccal midazolam

SE treatmentSE treatment
2
nd
line agents
–phenytoin 20 mg/kg @ 1mg/kg/min (upto 50 mg/min)
–fosphenytoin 15-20 PE/kg @ 3 mg/kg/min (upto 150
mg/min)
3
rd
line agents
–phenobarbital 20mg/kg @ 100mg/min
–repeat prn 5-10mg/kg
–maximum 40 mg/kg or 1 gram

refractory SE treatmentrefractory SE treatment
consider midazolam
–0.2 mg/kg bolus
–then 1-10 mcg/kg/min infusion
induce barbiturate coma
–pentobarbital 5-15 mg/kg @ 25 mg/min
–then 1-5 mg/kg/hour
others
–valproic acid
–paraldehyde, chloral hydrate
–propofol, inhalational anesthesia, paralysis
–lidocaine

approach – stable post szapproach – stable post sz
history
–pre-seizure
what was child doing when attack occurred
precipitants – fever, trauma, poisoning, drug/med use
aura
–deizure
what movements – incl. eyes
how long
LOC?
consequences – resp distress, incontinence, injury
–post seizure
Post-ictal

approach to stable patientapproach to stable patient
physical directed towards
–systemic disease
–infection
–toxic exposure
–focal neuro signs

laboratorylaboratory
blood glucose?
electrolytes?
magnesium, calcium?
anything at all?
what about first time seizures? recurrent?

laboratorylaboratory
yes if…
–neonatal
–abnormal mental status persistent
–diabetics, renal disease
–diuretic use
–dehydration
–malnourishment

laboratorylaboratory
septic work-up (CBC, BC, urine C+S, CXR, LP)
–as indicated
sick child
< 12 - 18 mo
therapeutic drug levels
other
–ABG
–toxicologic screen
–TORCH, ammonia, amino acids in neonate
–CPK, lactate, prolactin – ?confirm seizure?

lumbar puncturelumbar puncture
patients at greatest risk for meningitis
–under 18 months of age
–seizure in the ED
–focal or prolonged seizure
–seen a physician within the past 48 hours
other indications
–concern about follow-up
–prior treatment with antibiotics
The American Academy of Pediatrics
“strongly consider” in infants under 12 months of age with a first
febrile seizure

neuroimagingneuroimaging
WHO? which patients?
WHAT? CT vs. MRI
–ultrasound in neonates
WHEN? emergent vs. elective

ACEP guidelines - >6 yoACEP guidelines - >6 yo
consensus indication for non-contrast CT
first time seizure patients
–if suspect structural lesion
–partial onset seizure
–age > 40
–no other identified cause
recurrent seizure patients
–change in pattern
–prolonged post-ictal period
–worsening mental status

neuroimagingneuroimaging
predictors of abnormal findings of computed tomography of the head in
pediatric patients presenting with seizures

Warden CR - Ann Emerg Med - 01-Apr-1997; 29(4): 518-23
–retrospective case series
–predicts CT scan results normal if
no underlying high-risk condition
–malignancy, NCT, recent CHI, or recent CSF shunt revision
older than 6 months
sustained a seizure of 15 minutes or less
no new-onset focal neurologic deficit
–not prospectively validated

emergent EEG?emergent EEG?
not generally available on emergent basis
but consider in..
–persistent altered mental status (?non
convulsive status epilepticus)
–paralyzed patients
–pharmacologic coma

dispositiondisposition
can be discharged home if
–single seizure
–stable, returning to baseline neuro status
–no underlying condition/cause requiring
treatment in hospital
–arranged follow-up

EEG – 1EEG – 1
stst
non-febrile seizure non-febrile seizure
follow-up EEG
–within 24h

Lancet 1998;352:1007-11

improved pick-up 51% vs 34%

? how soon do we get ours ?
–inter-ictal EEG’s often normal

neuro may do sleep deprivation study (provocation)
–absence epilepsy and infantile spasms are invariably
associated with an abnormal EEG
–spike and wave 3HZ

idiopathic seizureidiopathic seizure
recurrence risk stratification
–normal EEG – 25%
–abN EEG – 60%
–2
nd
seizure – 75%

neuroimagingneuroimaging
MRI superior
not emergently available
?defer imaging until follow-up MRI
available in low risk patients?

treatmenttreatment
correct underlying pathology, if any
antipyretics ineffective in febrile seizure
anti-epileptic choice often trial and error

no anti-epileptic 100% effective
febrile seizure – diazepam, phenobarbital, valproic acid
–Currently AAP does not recommend

neonatal - phenobarbital
generalized TC – phenytoin, phenobarbital, carbamazepine, valproic acid,
primidone
absence – ethosuximide, valproic acid
new anti-epileptics – felbamate, gabapentin, lamotrigine, topiramate,
tiagabine, vigabatrine
in consultation with neurologist

pediatric headachepediatric headache

case 5case 5
14 year old
mother’s chief complaint - “having headaches all the
time, getting worse, this is not normal!!” etc. etc……..
V/S N
looks in discomfort but otherwise well
approach?
–treatment
–imaging?

classificationclassification
classify based on temporal pattern
acute headaches
–any febrile illness, sinus/dental infection, intracranial
infection/bleed (AVM,SAH,trauma)
acute recurrent
chronic progressive
chronic non-progressive
–tension, psychogenic, post-traumatic, ocular refractive
error

acute recurrent headacheacute recurrent headache
migraine
other
–cluster headache – typically >10 yo
–sinusitis
–vascular malformation

migraine - terminologymigraine - terminology
classic migraine
–biphasic
neuro aura
headache, N/V, anorexia, photophobia
–either unilateral (older) / bilateral(younger) or both
common migraine
–malaise, dizziness, N/V, feels and looks sick
–unilateral/bilateral
migraine equivalent/”complicated migraine”
–transient neuro deficits
–+/- headache
migraine variants
–Cyclic N/V, abdo pain
–BPV

migraine treatmentmigraine treatment
very little supporting evidence for pharmacologic
treatment in children compared to adults
classes of medication
–acetaminophen
–NSAIDS
–phenothiazines (dopamine antagonists)
–dihydroergotamine
–triptans

the simple stuffthe simple stuff
acetaminophen 15 mg/kg PO 30mg/kg PR
ibuprofen 10 mg/kg PO
Hamalainen ML Ibuprofen or acetaminophen for the acute treatment
of migraine in children: A double-blind, randomized, placebo-
controlled, crossover study
Neurology 48:103-107, 1997
–N = 88 age 4-16
–relief at 2 hours
acetaminophen 54%
ibuprofen 68%

other NSAIDSother NSAIDS
naproxen 5-7 mg/kg PO
–no pediatric evidence
ketorolac IV 0.5 mg/kg (max 30mg dose)
–not studied in pediatric migraine
–not approved <16 yo
–Houck CS – Safety of intravenous ketorolac in children and cost savings with a unit
dosing system. J Pediatr - 01-Aug-1996; 129(2): 292-6

1747 children

0.2% hypersensitivity

0.1% renal complications (in patients with renal disease)

0.05% gi bleed

dihydroergotaminedihydroergotamine
not approved
?dose – 0.1 – 0.5 mg IV
not studied in emergency population
Linder SL – Treatment of childhood migraine with dihydroergotamine
mesylate Headache - 1994 Nov-Dec; 34(10): 578-80
–N = 30
–inpatient protocol
–IV DHE and PO metoclopramide – average 5 doses!
–80% response

phenothiazinesphenothiazines
again no studies
metoclopramide 1-2 mg/kg IV (max 10mg)
prochloperazine 0.1 – 0.15 mg/kg IV/IM/PO/PR
(max 10mg)
children may be more susceptible to EPS
–? pre-treat with benadryl

triptanstriptans
mostly studied in adolescent groups
sumitriptan subcutaneous 0.06mg/kg
–Linder S: Subcutaneous sumatriptan in the clinical setting: The first 50 consecutive
patients with acute migraine in a pediatric neurology office practice. Headache 36:419–
422, 1996
–N = 50 age 6-18
–78% effective at 2 hours
–6% recurrence
sumitriptan intranasal
–long term treatment studies done
–no emergent studies
triptans PO
–studies plagued by high placebo response

chronic progressive headachechronic progressive headache
least common presentation
most worrisome for increased ICP
–pseudotumor cerebri
–space occupying lesion

imaging indications? discussimaging indications? discuss
lack of evidence to help
–small studies lack power to guide decision
making
MRI preferred in non-urgent indication

imaging indications? discussimaging indications? discuss
classically based on historical and physical
–sudden severe headache
–rapid increase over days - weeks
–chronic progressive
–suggestive of increased ICP
severe nocturnal headache (wakes or upon waking), changes in pain with
position, coughing
–following head trauma
–persistent neuro findings
? include migraine equivalents ?
–growth abnormality
–age (? <3 ?)
Tags